4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-002052
Director acquired 9,127 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2025-01-03 | Option exercise | +9,127 | $9.00 | $82,143 | 57,137 | D |
| Derivatives | |||||||
| Coleman Mark Director | 2025-01-03 | Option exercise · Stock Option (Right to Buy) | −9,127 | 0 | D | ||
Loading xslF345X05/ownership.xml…